| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
47,114
|
92,773
|
71,331
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
47,114
|
92,773
|
71,331
| |
|
Operating Expenses |
|
Research Development | 118,595 | 108,582 | 99,232 |
|
Selling General and Administrative | (18,673) | 22,719 | 21,070 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(52,808)
|
(38,528)
|
(48,971)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 752 | 327 | 1,197 |
|
Earnings Before Interest And Taxes | (52,056) | (38,201) | (47,774) |
|
Interest Expense | 1,908 | 1,841 | 1,910 |
|
Income Before Tax | (53,964) | (40,042) | (49,684) |
|
Income Tax Expense |
-
|
-
| (700) |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (53,964) | (40,042) | (48,984) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(53,964)
|
(40,042)
|
(48,984)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(53,964)
|
(40,042)
|
(48,984)
|
|
0.08%